Solid Biosciences Inc. Shares Outstanding (Cover Page)
Solid Biosciences Inc. (SLDB) had Shares Outstanding (Cover Page) of 107.23 million shares as of 2026-08-04, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-04: Entity Common Stock, Shares Outstanding 107.23M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 98.45M shares.
- 2026-03-16: Entity Common Stock, Shares Outstanding 98.39M shares.
- 2025-10-29: Entity Common Stock, Shares Outstanding 77.91M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-04 | 107.23M shares 10-Q · filed 2026-08-06 |
| 2026-05-08 | 98.45M shares 10-Q · filed 2026-05-12 |
| 2026-03-16 | 98.39M shares 10-K · filed 2026-03-19 |
| 2025-10-29 | 77.91M shares 10-Q · filed 2025-11-03 |
| 2025-08-07 | 77.87M shares 10-Q · filed 2025-08-12 |
| 2025-05-12 | 77.52M shares 10-Q · filed 2025-05-15 |
| 2025-03-03 | 77.49M shares 10-K · filed 2025-03-06 |
| 2024-11-01 | 39.95M shares 10-Q · filed 2024-11-06 |
| 2024-08-09 | 38.60M shares 10-Q · filed 2024-08-13 |
| 2024-05-10 | 38.38M shares 10-Q · filed 2024-05-15 |
| 2024-03-05 | 37.76M shares 10-K · filed 2024-03-13 |
| 2023-11-06 | 20.18M shares 10-Q · filed 2023-11-08 |
| 2023-08-08 | 20.06M shares 10-Q · filed 2023-08-14 |
| 2023-05-07 | 19.60M shares 10-Q · filed 2023-05-11 |
| 2023-03-20 | 19.57M shares 10-K · filed 2023-03-23 |
| 2022-11-04 | 7.53M shares 10-Q · filed 2022-11-10 |
| 2022-08-08 | 112.99M shares 10-Q · filed 2022-08-11 |
| 2022-04-22 | 112.81M shares 10-Q · filed 2022-04-27 |
| 2022-02-16 | 110.47M shares 10-K · filed 2022-03-14 |
| 2021-11-01 | 110.30M shares 10-Q · filed 2021-11-03 |
| 2021-08-10 | 110.30M shares 10-Q · filed 2021-08-16 |
| 2021-05-10 | 110.30M shares 10-Q · filed 2021-05-14 |
| 2021-02-16 | 85.13M shares 10-K · filed 2021-03-15 |
| 2020-11-01 | 60.45M shares 10-Q · filed 2020-11-05 |
| 2020-08-01 | 46.10M shares 10-Q · filed 2020-08-06 |
| 2020-05-01 | 46.07M shares 10-Q · filed 2020-05-07 |
| 2020-02-15 | 46.07M shares 10-K · filed 2020-03-12 |
| 2019-11-01 | 45.99M shares 10-Q · filed 2019-11-12 |
| 2019-08-01 | 46.00M shares 10-Q · filed 2019-08-14 |
| 2019-05-01 | 35.41M shares 10-Q · filed 2019-05-13 |
| 2019-02-15 | 35.42M shares 10-K · filed 2019-03-13 |
| 2018-11-01 | 35.43M shares 10-Q · filed 2018-11-13 |
| 2018-08-01 | 35.43M shares 10-Q · filed 2018-08-10 |
| 2018-05-01 | 35.46M shares 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |